Curever Pharma Private Limited, a active private limited company, was established on 19 January 2021 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2021PTC353725. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 14 professional, Its leadership includes Prashant Srivastava (Director), Kaushik Balakrishnan Natesan (Director). Past directors included Davinder Bhardwaj, Ambarish Chatterjee, Prashant Srivastava. It holds no open charges and ₹20.00 Cr settled loans. Its latest AGM occurred on 16 September 2025, with the balance sheet filed on 31 March 2025. It is based at 501, Crystal Plaza-158, Cts No 560B, C.S.T. Road, Kalina, Mumbai, Maharashtra, 400098.
U24230MH2021PTC353725
353725
19 January 2021
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Curever Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Srivastava | Director | 04 Oct 2022 | Current |
| Kaushik Balakrishnan Natesan | Director | 19 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 21 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 10 Mar 2023 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curever Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 73.84% decrease. The company also saw a substantial improvement in profitability, with a 13.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 85.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Curever Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹200,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2022 | Others | ₹20.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Curever Pharma has a workforce of 14 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Curever Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curever Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Curever Pharma Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Curever Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge registered on 31 Jan 2022 via Charge ID 100535387 with Others was fully satisfied on 14 Feb 2023. was documented.
Progress on Prashant Srivastava was appointed as a Director was appointed as a Director on 04 Oct 2022 & has been associated with this company since 3 years 3 months . was documented.
The activity A charge with Others amounted to Rs. 200.00 M with Charge ID 100535387 was registered on 31 Jan 2022. was completed.
Progress on Kaushik Balakrishnan Natesan was appointed as a Director was appointed as a Director on 19 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Curever Pharma Private Limited is U24230MH2021PTC353725.
Curever Pharma Private Limited is headquartered at 501, Crystal Plaza-158, Cts No 560B, C.S.T. Road, Kalina, Mumbai, Maharashtra, 400098.
Curever Pharma Private Limited was incorporated on 19 January 2021.
The current directors of Curever Pharma Private Limited are
The primary industry of Curever Pharma Private Limited is Trade.
Curever Pharma Private Limited is unlisted.
The authorized capital of Curever Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX